Uncategorized

Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock – July 28, 2023

Inozyme Pharma, Inc. announced the pricing of an underwritten public offering of 12,500,000 shares of its common stock at a price of $4.80 per share, for aggregate gross proceeds of approximately $60 million, before deducting underwriting discounts and commissions and other offering expenses.

Inozyme Pharma, Inc. Announces Pricing of Public Offering of Common Stock – July 28, 2023 Read More »

Tonix Pharmaceuticals Announces Pricing of $7 Million Public Offering

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”)today announced it has entered into a securities purchase agreement for the purchase and sale of 7,000,000 shares of its common stock (or common stock equivalents in lieu thereof) and warrants to purchase up to an aggregate of 7,000,000 shares of common stock in a public

Tonix Pharmaceuticals Announces Pricing of $7 Million Public Offering Read More »

Inteligencia artificial para identificar variaciones en el genoma humano asociadas a enfermedades

Una prometedora iniciativa se servirá de la inteligencia artificial para crear un sistema capaz de identificar en genomas humanos las variaciones que estén asociadas a enfermedades.   Un equipo de investigadores del Instituto Universitario Valenciano de Investigación en I …

Inteligencia artificial para identificar variaciones en el genoma humano asociadas a enfermedades Read More »

Scroll to Top